Active Psoriatic Arthritis (PsA) Treatment - TREMFYA Learn about TREMFYA® (guselkumab) for the treatment of active psoriatic arthritis (PsA) in adults See full Prescribing Safety Information Important Safety Information; Full Prescribing Information; Medication Guide; Safe Returns; The support and resources provided by TREMFYA withMe are not intended to give medical advice, replace a
About TREMFYA® for PsA | TREMFYA® (guselkumab) TREMFYA ® is a biologic treatment, and the first medication of its kind to be approved by the Food and Drug Administration (FDA) for adults with active psoriatic arthritis TREMFYA ® Legacy TREMFYA ® has 15+ years of combined clinical research* and 7+ years on the market across indications
Tremfya Results | TREMFYA® (guselkumab) TREMFYA® is a prescription medicine approved for the treatment of adults with active psoriatic arthritis (PsA) In two medical studies, more than half of patients treated with TREMFYA ® had at least a 20% improvement in PsA symptoms (joint pain, stiffness, swelling) at 24 weeks compared to placebo Individual results may vary
What is Psoriatic Arthritis (PsA) | TREMFYA® (guselkumab) It’s a chronic, or long-term, disease, and we don’t know the exact cause If you have psoriatic arthritis, your immune system attacks healthy tissues like the skin and joints That’s why it’s called an autoimmune disease Psoriatic arthritis includes symptoms in areas such as the joint and skin
TREMFYA® Cost Savings Support for PsA | TREMFYA® (guselkumab) Depending on the type of insurance you have, or even if you don’t have insurance, TREMFYA withMe can provide information about resources that may help you with your out-of-pocket costs To learn more, click here If you use commercial or private insurance, you may be eligible for the TREMFYA withMe Savings Program Eligible patients pay $0
Official Consumer Website for TREMFYA® (guselkumab) Learn about treatment with TREMFYA® (guselkumab) across all uses, including the support program, TREMFYA withMe, on the official patient website See full Prescribing Safety Info people with psoriatic arthritis 85% of people with psoriatic arthritis also have psoriasis (PsO) on the skin? Source: CreakyJoints
SELECTED IMPORTANT SAFETY INFORMATION - TREMFYA for TREMFYA® to learn more about these and other risks for TREMFYA® Discuss any questions you have with your healthcare provider TREMFYA® is a prescription medicine used to treat adults with active psoriatic arthritis 1 For adults with active psoriatic arthritis With less joint pain, stiffness, and swelling at 24 weeks Individual results
About TREMFYA® for PsO | TREMFYA® (guselkumab) TREMFYA ® is the first medication of its kind to be approved by the Food and Drug Administration (FDA) in 2017 to treat adults with moderate to severe plaque psoriasis In July 2020, the FDA also approved TREMFYA ® to treat adults with active psoriatic arthritis
Aprende - TREMFYA TREMFYA® es un medicamento de venta con receta que se usa para tratar a adultos con artritis psoriásica activa INFORMACIÓN IMPORTANTE DE SEGURIDAD ¿Qué es lo más importante que debo saber sobre TREMFYA®? TREMFYA® es un medicamento de venta con receta que podría causar efectos secundarios graves, incluyendo: • ®Reacciones alérgicas
Official Consumer Website for TREMFYA® (guselkumab) Learn about treatment with TREMFYA® (guselkumab) across all uses, including the support program, TREMFYA withMe, on the official patient website See full Prescribing Safety Info Moderate to severe plaque psoriasis Active psoriatic arthritis Moderately to severely active ulcerative colitis Moderately to severely active Crohn’s disease